Search Patents
  • Patent number: 5418155
    Abstract: Genetic material encoding luciferase from the marine coelenterate Renilla has been isolated and characterized. This genetic material allows the production of peptides for use as labels in bioluminescence assays or can itself be directly used to identify luciferase genes from related organisms.
    Type: Grant
    Filed: December 14, 1993
    Date of Patent: May 23, 1995
    Assignee: University of Georgia Research Foundation, Inc.
    Inventors: Milton J. Cormier, William W. Lorenz
  • Patent number: 5292658
    Abstract: Genetic material encoding luciferase from the marine coelenterate Renilla has been isolated and characterized. This genetic material allows the production of peptides for use as labels in bioluminescence assays or can itself be directly used to identify luciferase genes from related organisms.
    Type: Grant
    Filed: June 17, 1993
    Date of Patent: March 8, 1994
    Assignee: University of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center
    Inventors: Milton J. Cormier, William W. Lorenz
  • Patent number: 6436682
    Abstract: Isolated and purified nucleic acid molecules that encode a luciferase from Renilla mulleri, Gaussia and Pleuromamma, and the proteins encoded thereby are provided. Isolated and purified nucleic acids encoding green fluorescent proteins from the genus Renilla and Ptilosarcus, and the green fluorescent proteins encoded thereby are also provided. Compositions and combinations comprising the green fluorescent proteins and/or the luciferase are further provided.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: August 20, 2002
    Assignee: Prolume, Ltd.
    Inventors: Bruce J. Bryan, Christopher Szent-Gyorgyi
  • Publication number: 20080299592
    Abstract: The compositions described herein shift the light output of luciferases to the near-IR by resonance energy transfer to a targetable near-IR fluorophore.
    Type: Application
    Filed: February 29, 2008
    Publication date: December 4, 2008
    Inventor: Stephen C. Miller
  • Patent number: 4412001
    Abstract: The present invention provides a novel means for the isolation of bacterial luciferase and a novel affinity resin useful in said isolation.
    Type: Grant
    Filed: December 3, 1981
    Date of Patent: October 25, 1983
    Assignee: Board of Trustees of The University of Illinois
    Inventors: Thomas O. Baldwin, Thomas F. Holzman
  • Patent number: 5674713
    Abstract: DNA compositions and methods of constructing and using the same consisting of DNA sequences encoding luciferase activity, or DNA sequences encoding hybrid molecules exhibiting luciferase activity and a second biological activity that are useful in performing biological assays.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: October 7, 1997
    Assignee: The Regents of the University of California
    Inventors: Marlene DeLuca McElroy, deceased, Donald Raymond Helinski, Keith Vernon Wood, Jeffrey Roux De Wet, David Wing Ow, Stephen Herbert Howell
  • Publication number: 20100184185
    Abstract: The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.
    Type: Application
    Filed: October 22, 2007
    Publication date: July 22, 2010
    Inventors: Stefan Golz, Bernd Kalthof, Svetlana Markova, Ludmila Frank, Eugene Vysotski
  • Publication number: 20100105090
    Abstract: The invention relates to the nucleotide and amino acid sequences and to the activity and use of the secreted MLuc7 luciferase.
    Type: Application
    Filed: January 26, 2008
    Publication date: April 29, 2010
    Applicant: BAYER HEALTHCARE AG
    Inventors: Stefan Golz, Eugene Vysotski, Svetlana Markova, Anna Tumenceva
  • Patent number: 5604123
    Abstract: The present invention provides luciferase with an amino acid sequence shown in FIG. 1, a gene encoding the the same, a recombinant vector DNA comprising the gene ligated at a site downstream of a promoter which can be expressed in a host cell, a transformant prepared by transforming the host cell with the recombinant vector DNA and a process of producing luciferase using the transformant.
    Type: Grant
    Filed: June 15, 1994
    Date of Patent: February 18, 1997
    Assignee: Toray Industries, Inc.
    Inventors: Jun Kazami, Haruji Nakamura, Toshio Goto, deceased
  • Publication number: 20150111233
    Abstract: Luciferases which are different from those known heretofore have been desired. A luciferase mutant comprising an amino acid sequence in which at least one amino acid selected from the group consisting of valine at the position of 44, alanine at the position of 54 and tyrosine at the position of 138 is substituted with other amino acid(s) in the amino acid sequence of SEQ ID NO: 2.
    Type: Application
    Filed: October 17, 2014
    Publication date: April 23, 2015
    Inventors: Satoshi INOUYE, Junichi SATO
  • Publication number: 20140201855
    Abstract: Described are mutant luciferases, nucleic acids that encode them, cells and animals expressing them, methods of use thereof, and kits.
    Type: Application
    Filed: February 9, 2012
    Publication date: July 17, 2014
    Applicant: UNIVERSITY OF MASSACHUSETTS
    Inventors: Stephen C. Miller, David Mofford, Katryn Harwood
  • Patent number: 6852499
    Abstract: The present invention provides a detection method and a method of manufacturing a detection kit, both characterized by use of an organic sulfur reagent, and which are effective at low concentration of the reagent, are inexpensive, and have reduced unpleasent odor. Provided is a reagent kit for detecting a Coleoptera luciferase, comprising an organic sulfur reagent having the atomic sequence of sulfur-carbon-sulfur in its chemical structure, a luciferin, adenosine triphosphate and a magnesium ion. Also provide is a method for detecting a Coleoptera luciferase, comprising step 1 of mixing an aqueous solution, containing an organic sulfur reagent having the atomic sequence of sulfur-carbon-sulfur in its chemical structure, a luciferin, adenosine triphosphate and a magnesium ion, with a sample containing a Coleoptera luciferase, to give a mixed solution; and step 2 of measuring the light emitted in the mixed solution.
    Type: Grant
    Filed: March 13, 2003
    Date of Patent: February 8, 2005
    Assignees: Toyo B-Net Co., Ltd.
    Inventors: Masayuki Ryufuku, Hozumi Tanaka, Chie Suzuki
  • Publication number: 20130115641
    Abstract: The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.
    Type: Application
    Filed: July 18, 2012
    Publication date: May 9, 2013
    Applicant: Bayer Intellectual Property GmbH
    Inventors: Stefan GOLZ, Bernd Kalthof, Svetlana Markova, Ludmila Frank, Eugene Vysotski
  • Publication number: 20090136998
    Abstract: Briefly described, embodiments of this disclosure include polynucleotides that encode mutant Cnidarian luciferases that exhibit modulated properties as compared to the corresponding wild-type luciferases, and the modulated properties include at least one of: modulated stability; enhanced light output; and modulated emission maximum. Embodiments of the present disclosure also include polypeptides or fragments thereof encoded by the polynucleotides, constructs including the polynucleotide, expression cassettes, cells, methods of producing the polynucleotides and polypeptides, antibodies, transgenic cells and/or animals, kits, and the like.
    Type: Application
    Filed: September 6, 2006
    Publication date: May 28, 2009
    Inventors: Sanjiv S. Gambhir, Andreas M. Loening, Anna M. Wu
  • Patent number: 4581335
    Abstract: A process for producing a cloned luciferase-synthesizing microorganism, capable of the expression of bioluminescence, is disclosed. The process involves isolation and digestion of the genomic DNA of an appropriate bioluminescent microorganism, such as Vibrio harveyi, to obtain a DNA fragment which codes for luciferase. The DNA fragment is inserted into a pre-existing cloning vehicle under the control of an expression promoter, thereby producing a recombinant or derivatized cloning vehicle. A host microorganism is transformed with the derivatized cloning vehicle, cultured and purified for the expression of bioluminescence.
    Type: Grant
    Filed: December 1, 1982
    Date of Patent: April 8, 1986
    Assignee: Texas A&M University System
    Inventor: Thomas O. Baldwin
  • Patent number: 8236540
    Abstract: The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.
    Type: Grant
    Filed: October 22, 2007
    Date of Patent: August 7, 2012
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Stefan Golz, Bernd Kalthof, Svetlana Markova, Ludmila Frank, Eugene Vysotski
  • Patent number: 8143013
    Abstract: An object of the present invention is to produce a luminescent probe that has less biological effects, efficiently emits visible to near-infrared light, which is excellent for the imaging of individuals, and the use thereof. The present invention provides a sugar chain-containing-luciferase derivative, wherein an organic fluorescent dye is bonded to the luciferase through the sugar chain.
    Type: Grant
    Filed: August 7, 2008
    Date of Patent: March 27, 2012
    Assignee: National Institute of Advanced Industrial Science and Technology
    Inventors: Yoshihiro Ohmiya, Chun Wu
  • Publication number: 20140227759
    Abstract: An isolated polynucleotide encoding a modified luciferase polypeptide and substrates. The OgLuc variant polypeptide has at least 60% amino acid sequence identity to SEQ ID NO: 1 and at least one amino acid substitution at a position corresponding to an amino acid in SEQ ID NO: 1. The OgLuc variant polypeptide has at least one of enhanced luminescence, enhanced signal stability, and enhanced protein stability relative to the corresponding polypeptide of the wild-type Oplophorus luciferase.
    Type: Application
    Filed: January 21, 2014
    Publication date: August 14, 2014
    Applicant: PROMEGA CORPORATION
    Inventors: Brock Binkowski, Lance P. Encell, Mary Hall, Matthew B. Robers, Michael R. Slater, Keith V. Wood, Monika G. Wood
  • Patent number: 5670356
    Abstract: A modified form of beetle luciferase, which has been engineered for improved genetic reporting, is disclosed. The modified form contains one or more new features. Chief among these is removal of the peroxisomal translocation sequence to yield a cytoplasmic form of the enzyme. Other changes include removal of potentially interfering restriction sites and genetic regulatory sites from the gene, improvement of the codon usage for mammalian cells. The modified luciferase reporter enzyme is also devoid of potential N-glycosylation targets to minimize post-translational modification and remains in the cytoplasm of host cells to optimize substrate availability.
    Type: Grant
    Filed: December 12, 1994
    Date of Patent: September 23, 1997
    Assignee: Promega Corporation
    Inventors: Bruce A. Sherf, Keith V. Wood
  • Publication number: 20110229955
    Abstract: Briefly described, embodiments of this disclosure include polynucleotides that encode mutant Cnidarian luciferases that exhibit modulated properties as compared to the corresponding wild-type luciferases, and the modulated properties include at least one of: modulated stability; enhanced light output; and modulated emission maximum. Embodiments of the present disclosure also include polypeptides or fragments thereof encoded by the polynucleotides, constructs including the polynucleotide, expression cassettes, cells, methods of producing the polynucleotides and polypeptides, antibodies, transgenic cells and/or animals, kits, and the like.
    Type: Application
    Filed: March 24, 2011
    Publication date: September 22, 2011
    Applicants: The Board of Trustees of the Leland Stanford Junior University, The Regents of the University of California
    Inventors: Sanjiv S. Gambhir, Andreas M. Loening, Anna M. Wu